Cargando…

Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches

Identification and quantitative monitoring of mutant BCR-ABL1 subclones displaying resistance to tyrosine kinase inhibitors (TKIs) have become important tasks in patients with Ph-positive leukemias. Different technologies have been established for patient screening. Various next-generation sequencin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Preuner, Sandra, Barna, Agnes, Frommlet, Florian, Czurda, Stefan, Konstantin, Byrgazov, Alikian, Mary, Machova Polakova, Katerina, Sacha, Tomasz, Richter, Johan, Lion, Thomas, Gabriel, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881468/ https://www.ncbi.nlm.nih.gov/pubmed/27136541 http://dx.doi.org/10.3390/ijms17050642

Ejemplares similares

Role of Epigenetics in Chronic Myeloid Leukemia
por: Machova Polakova, Katerina, et al.
Publicado: (2013)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
por: Prochazka, Katharina T., et al.
Publicado: (2019)

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing
por: Linhartova, Jana, et al.
Publicado: (2015)

cFinder: definition and quantification of multiple haplotypes in a mixed sample
por: Niklas, Norbert, et al.
Publicado: (2015)

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
por: Cross, N C P, et al.
Publicado: (2015)

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
por: Srutova, Klara, et al.
Publicado: (2018)

In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants
por: Soverini, Simona, et al.
Publicado: (2016)

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
por: Cross, Nicholas C. P., et al.
Publicado: (2023)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report
por: McGrath, Mary, et al.
Publicado: (2021)

Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia
por: Vráblová, Lucia, et al.
Publicado: (2023)

Imatinib in Chronic Myeloid Leukemia: an Overview
por: Sacha, Tomasz
Publicado: (2014)

AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome
por: Koblihova, Jitka, et al.
Publicado: (2018)

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022)

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)

Subclonal heterogeneity and evolution in breast cancer
por: Mavrommati, Ioanna, et al.
Publicado: (2021)

Accurate Identification of Subclones in Tumor Genomes
por: Ahmadinejad, Navid, et al.
Publicado: (2022)

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1(T315I)+ clones in TKI-resistant CML
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2019)

Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
por: Schäfer, Vivien, et al.
Publicado: (2021)

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
por: Curik, Nikola, et al.
Publicado: (2021)

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia
por: Heller, G, et al.
Publicado: (2016)

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017)

Expression patterns of microRNAs associated with CML phases and their disease related targets
por: Machová Poláková, Kateřina, et al.
Publicado: (2011)

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
por: Nadeu, F, et al.
Publicado: (2018)

Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML
por: Tiso, F., et al.
Publicado: (2022)

Frequent loss of metastatic ability in subclones of Apc, Kras, Tgfbr2, and Trp53 mutant intestinal tumor organoids
por: Morita, Atsuya, et al.
Publicado: (2023)

Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2017)

Relapse-Fated Subclones: Finding the Needle in the Haystack
por: Tesio, Melania
Publicado: (2020)

Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
por: Rampias, Theodoros
Publicado: (2020)

Automated Solid-Phase Subcloning Based on Beads Brought into Proximity by Magnetic Force
por: Hudson, Elton P., et al.
Publicado: (2012)

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY
por: Efficace, Fabio, et al.
Publicado: (2023)

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
por: Vaclova, Tereza, et al.
Publicado: (2021)

Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations
por: Antić, Željko, et al.
Publicado: (2020)

Subclonal variant calling with multiple samples and prior knowledge
por: Gerstung, Moritz, et al.
Publicado: (2014)

Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution
por: Bozic, Ivana, et al.
Publicado: (2016)

On measuring selection in cancer from subclonal mutation frequencies
por: Bozic, Ivana, et al.
Publicado: (2019)

Quantifying the influence of mutation detection on tumour subclonal reconstruction
por: Liu, Lydia Y., et al.
Publicado: (2020)

The evolution of lung cancer and impact of subclonal selection in TRACERx
por: Frankell, Alexander M., et al.
Publicado: (2023)

Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors
por: Byrgazov, Konstantin, et al.
Publicado: (2016)

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL
por: Pfirrmann, Markus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s40ee3fvho6papojqjkhrt87mf